Pfizer Limited (BOM:500680)
India · Delayed Price · Currency is INR 4,728.55
+128.05 (2.78%)
At close: Jul 10, 2026
Pfizer Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 25,197 | 22,814 | 21,932 | 24,248 | 26,110 |
| 25,197 | 22,814 | 21,932 | 24,248 | 26,110 | |
Revenue Growth (YoY) | 10.45% | 4.02% | -9.55% | -7.13% | 16.54% |
Cost of Revenue | 8,914 | 8,158 | 7,983 | 8,778 | 9,529 |
Gross Profit | 16,282 | 14,655 | 13,949 | 15,469 | 16,581 |
Selling, General & Admin | 4,315 | 4,289 | 4,337 | 3,935 | 4,784 |
Other Operating Expenses | 2,920 | 2,947 | 3,219 | 3,434 | 3,425 |
Operating Expenses | 7,812 | 7,844 | 8,179 | 8,423 | 9,359 |
Operating Income | 8,470 | 6,812 | 5,770 | 7,046 | 7,222 |
Interest Expense | -94.8 | -84.1 | -154.1 | -133.9 | -104.9 |
Interest & Investment Income | 1,762 | 1,573 | 1,716 | 854.9 | 489.4 |
Currency Exchange Gain (Loss) | -5.5 | -2.1 | -9.5 | -12.4 | -15 |
Other Non Operating Income (Expenses) | 105.4 | 143.2 | 83.4 | 72.7 | 76.3 |
EBT Excluding Unusual Items | 10,237 | 8,442 | 7,406 | 7,827 | 7,668 |
Merger & Restructuring Charges | - | - | - | -1,363 | - |
Gain (Loss) on Sale of Assets | -0.9 | -15.3 | -30.5 | 0.5 | 45.8 |
Legal Settlements | - | - | 79.5 | - | - |
Other Unusual Items | -491.6 | 1,733 | 0.2 | 1,739 | 12.3 |
Pretax Income | 9,757 | 10,161 | 7,461 | 8,240 | 7,729 |
Income Tax Expense | 2,532 | 2,485 | 1,947 | 2,001 | 1,603 |
Net Income | 7,224 | 7,676 | 5,513 | 6,239 | 6,126 |
Net Income to Common | 7,224 | 7,676 | 5,513 | 6,239 | 6,126 |
Net Income Growth | -5.88% | 39.23% | -11.64% | 1.86% | 23.10% |
Shares Outstanding (Basic) | 46 | 46 | 46 | 46 | 46 |
Shares Outstanding (Diluted) | 46 | 46 | 46 | 46 | 46 |
Shares Change (YoY) | - | - | -0.01% | - | - |
EPS (Basic) | 157.92 | 167.79 | 120.52 | 136.38 | 133.89 |
EPS (Diluted) | 157.92 | 167.79 | 120.52 | 136.38 | 133.89 |
EPS Growth | -5.88% | 39.23% | -11.63% | 1.86% | 23.10% |
Free Cash Flow | 9,423 | 6,316 | 2,379 | 2,907 | 6,518 |
Free Cash Flow Per Share | 205.99 | 138.06 | 52.01 | 63.54 | 142.46 |
Dividend Per Share | 75.000 | 35.000 | 35.000 | 35.000 | 35.000 |
Dividend Growth | 114.29% | - | - | - | 16.67% |
Gross Margin | 64.62% | 64.24% | 63.60% | 63.80% | 63.51% |
Operating Margin | 33.62% | 29.86% | 26.31% | 29.06% | 27.66% |
Profit Margin | 28.67% | 33.65% | 25.14% | 25.73% | 23.46% |
Free Cash Flow Margin | 37.40% | 27.68% | 10.85% | 11.99% | 24.96% |
EBITDA | 8,691 | 7,052 | 5,985 | 7,704 | 7,879 |
EBITDA Margin | 34.49% | 30.91% | 27.29% | 31.77% | 30.18% |
D&A For EBITDA | 221.2 | 239.8 | 215.1 | 658.5 | 656.8 |
EBIT | 8,470 | 6,812 | 5,770 | 7,046 | 7,222 |
EBIT Margin | 33.62% | 29.86% | 26.31% | 29.06% | 27.66% |
Effective Tax Rate | 25.96% | 24.46% | 26.10% | 24.28% | 20.74% |
Revenue as Reported | 27,076 | 24,536 | 23,737 | 25,258 | 26,736 |
Advertising Expenses | 617.4 | 567.5 | 855.9 | 615.9 | 743.8 |